SciELO - Scientific Electronic Library Online

vol.29 número4Rol del estado como autoridad reguladora de ensayos clínicos en el Perú¿Contribuyen los ensayos clínicos al desarrollo de la investigación en el Perú?: ¿cómo lograrlo? índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados




  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO


Revista Peruana de Medicina Experimental y Salud Publica

versión impresa ISSN 1726-4634


BAYONA, Andrés  y  FAJARDO, Natalia. Development of new drugs: opportunities and benefits for Peru. Rev. perú. med. exp. salud publica [online]. 2012, vol.29, n.4, pp.521-528. ISSN 1726-4634.

The development of innovative drugs allows coming up with new medicines to prevent and better treat illnesses. This improves people´s quality of life and makes it more productive. Therefore, the mission of pharmaceutical research is to develop safe and effective drugs. Clinical trials allow the evaluation of the safety and efficacy profiles of new medicines, medical devices and diagnostic tests. Research and development (R&D) of new drugs is a long and costly process, where out of every 5000 to 10000 new components that enter preclinical testing, only one is approved. Compared to 2011, drug development has increased by 7.6%. According to, 5% of the trials take place in Latin America, and Peru is in the fifth position. On the other hand, according to the Global Competitiveness Report issued by the World Economic Forum, Peru ranks 61st, its biggest challenges being the functioning of its public institutions, investment in R&D and technological capacity. The complexity of drug R&D results in a search for competitive places to develop clinical trials. Clinical Research is a humanized industry due to its ethical platform, stated in the guidelines of good clinical practices. This industry demands our country to develop a differentiating value that contributes to the development of knowledge and its competitiveness.

Palabras clave : Clinical research; Drugs, investigational; Knowledge.

        · resumen en Español     · texto en Español     · Español ( pdf )